Host immune response to Cryptosporidium parvum infection.

Species of the genus Cryptosporidium are protozoan parasites (Apicomplexa) that cause gastroenteritis in animals and humans. Of these Cryptosporidium parvum and Cryptosporidium hominis are the major causative agents of human cryptosporidiosis. Whereas infection is self-limiting in the immunocompetent hosts, immunocompromised individuals develop a chronic, life-threatening disease. As specific therapeutic or preventive interventions are not yet available, better understanding of the immune response to the parasite is required. This minireview briefly summarizes the factors involved in the innate and acquired immune response in this pathogen-host interaction with an emphasis on more recent data from mouse models of infection.

[1]  M. Loos.  Bacteria and Complement , 1985, Current Topics in Microbiology and Immunology.

[2]  S. Lacroix-Lamandé,et al.  Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. , 2007, Microbes and infection.

[3]  E. Vanopdenbosch,et al.  Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections , 1992, Infection and immunity.

[4]  A. White,et al.  High Levels of CXCL10 Are Produced by Intestinal Epithelial Cells in AIDS Patients with Active Cryptosporidiosis but Not after Reconstitution of Immunity , 2006, Infection and Immunity.

[5]  Deborah M. Brown,et al.  CD4 T Cell-Mediated Protection from Lethal Influenza: Perforin and Antibody-Mediated Mechanisms Give a One-Two Punch1 , 2006, The Journal of Immunology.

[6]  P. Ducrotte,et al.  Cryptosporidium parvum infection stimulates the secretion of TGF-β, IL-8 and RANTES by Caco-2 cell line , 2000, Parasitology Research.

[7]  G. Foster,et al.  Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon. , 2009, The Journal of infectious diseases.

[8]  R. Williams,et al.  Measurement of class specific antibody against cryptosporidium in serum and faeces from experimentally infected calves. , 1987, Research in veterinary science.

[9]  A. White,et al.  Paromomycin in cryptosporidiosis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Bout,et al.  Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. , 1994, Journal of immunology.

[11]  M. Murtaugh,et al.  NF-kappaB-mediated expression of iNOS promotes epithelial defense against infection by Cryptosporidium parvum in neonatal piglets. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[12]  J. Mead,et al.  Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice. , 2007, Experimental parasitology.

[13]  S. Nikiforow,et al.  Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation , 2003, Journal of Virology.

[14]  S. Thiel,et al.  Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection. , 2008, Molecular immunology.

[15]  M. Murtaugh,et al.  Nitric oxide synthase stimulates prostaglandin synthesis and barrier function in C. parvum-infected porcine ileum. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[16]  R. Watson,et al.  Alterations of the mucosal immune system due to Cryptosporidium parvum infection in normal mice. , 1996, Cellular immunology.

[17]  D. Mosier,et al.  Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. , 1993, The Journal of parasitology.

[18]  H. Okamura,et al.  Interleukin-18 regulates both Th1 and Th2 responses. , 2001, Annual review of immunology.

[19]  A. White,et al.  Expression of Tumor Necrosis Factor Alpha and Interleukin 1β in Jejuna of Volunteers after Experimental Challenge withCryptosporidium parvum Correlates with Exposure but Not with Symptoms , 2001, Infection and Immunity.

[20]  L. Perryman,et al.  Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice , 1994, Infection and immunity.

[21]  R. Sacco,et al.  In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen. , 1994, The Journal of parasitology.

[22]  J. D. Di Santo,et al.  Roles for NK Cells and an NK Cell-Independent Source of Intestinal Gamma Interferon for Innate Immunity to Cryptosporidium parvum Infection , 2009, Infection and Immunity.

[23]  S. Tzipori.  Opportunistic protozoa in humans , 1998 .

[24]  S. Tzipori,et al.  Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection , 2005, Parasitology Research.

[25]  F. Finkelman,et al.  Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. , 1991, Journal of immunology.

[26]  V McDonald,et al.  Host cell‐mediated responses to infection with Cryptosporidium , 2000, Parasite immunology.

[27]  R. Welsh,et al.  Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection1 , 2005, The Journal of Immunology.

[28]  H. Ogata,et al.  Human intestinal epithelial cell‐derived interleukin (IL)‐18, along with IL‐2, IL‐7 and IL‐15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes , 2004, Clinical and experimental immunology.

[29]  F. Finkelman,et al.  IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. , 1996, Journal of immunology.

[30]  S. Girardin,et al.  The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. , 2007, Seminars in immunology.

[31]  Enriquez Fj,et al.  Role of CD4+ TH1- and TH2-cell-secreted cytokines in cryptosporidiosis. , 1993 .

[32]  C. Nathan,et al.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Jutila,et al.  Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves , 1997, Infection and Immunity.

[34]  J. Revillard,et al.  Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. , 1994, The Journal of infectious diseases.

[35]  Wangxue Chen,et al.  Cryptosporidium parvum Infection in Gene-Targeted B Cell–Deficient Mice , 2003, The Journal of parasitology.

[36]  J. Heine,et al.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice , 1984, Infection and immunity.

[37]  W. Secor,et al.  Mucosal cytokine and antigen‐specific responses to Cryptosporidium parvum in IL‐12p40 KO mice , 2005, Parasite immunology.

[38]  L. M. Smith,et al.  Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice. , 2001, Experimental parasitology.

[39]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[40]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[41]  A. Dawson,et al.  Analysis of the kinetics, isotype and specificity of serum and coproantibody in lambs infected with Cryptosporidium parvum. , 1990, Research in veterinary science.

[42]  R. Hershberg,et al.  Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. , 2000, Immunology today.

[43]  C. Fichtenbaum,et al.  Cryptosporidium parvum Infection of Human Intestinal Xenografts in SCID Mice Induces Production of Human Tumor Necrosis Factor Alpha and Interleukin-8 , 1998, Infection and Immunity.

[44]  A. Hayward,et al.  Marrow-Derived CD40-Positive Cells Are Required for Mice To Clear Cryptosporidium parvum Infection , 2001, Infection and Immunity.

[45]  Wangxue Chen,et al.  Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice , 1993, Infection and immunity.

[46]  F. Castillo,et al.  Respiratory cryptosporidiosis: Case series and review of the literature , 1996, Infection.

[47]  R. Fayer,et al.  Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. , 1986, The Journal of infectious diseases.

[48]  D. Jack,et al.  Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. , 2000, Gastroenterology.

[49]  S. Lacroix-Lamandé,et al.  Role of Tumor Necrosis Factor Alpha in Development of Immunity against Cryptosporidium parvum Infection , 2006, Infection and Immunity.

[50]  F. Petry,et al.  Humoral immune response in IL‐12 and IFN‐γ deficient mice after infection with Cryptosporidium parvum , 2008, Parasite immunology.

[51]  R. Haque,et al.  Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. , 2009, The Journal of infectious diseases.

[52]  E. A. Havell,et al.  Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice , 1993, Infection and immunity.

[53]  Makiko Kobayashi,et al.  Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum , 2008, Infection and Immunity.

[54]  R. Pollok,et al.  The role of cytokines in the pathogenesis of Cryptosporidium infection , 2002, Current opinion in infectious diseases.

[55]  C. Wyatt,et al.  EVIDENCE FOR THE EMERGENCE OF A TYPE-1–LIKE IMMUNE RESPONSE IN INTESTINAL MUCOSA OF CALVES RECOVERING FROM CRYPTOSPORIDIOSIS , 2001, The Journal of parasitology.

[56]  I. Förster,et al.  Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection. , 2009, Immunobiology.

[57]  F. Laurent,et al.  Cryptosporidium parvum-Specific Mucosal Immune Response in C57BL/6 Neonatal and Gamma Interferon-Deficient Mice: Role of Tumor Necrosis Factor Alpha in Protection , 2001, Infection and Immunity.

[58]  D. Mosier,et al.  Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. , 1992, Journal of comparative pathology.

[59]  L. Perryman,et al.  Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection , 1994, Infection and immunity.

[60]  D. Bout,et al.  Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man. , 1994, Veterinary parasitology.

[61]  M. Loos,et al.  Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. , 1987, Immunology letters.

[62]  S. Lacroix-Lamandé,et al.  Role of Gamma Interferon in Chemokine Expression in the Ileum of Mice and in a Murine Intestinal Epithelial Cell Line after Cryptosporidium parvum Infection , 2002, Infection and Immunity.

[63]  L. M. Smith,et al.  CYTOKINE EXPRESSION AND SPECIFIC LYMPHOCYTE PROLIFERATION IN TWO STRAINS OF CRYPTOSPORIDIUM PARVUM-INFECTED γ-INTERFERON KNOCKOUT MICE , 2000, The Journal of parasitology.

[64]  J. O’Neill,et al.  Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  M. Bajaj‐Elliott,et al.  A potential role for interleukin‐18 in inhibition of the development of Cryptosporidium parvum , 2006, Clinical and experimental immunology.

[66]  J. Mead,et al.  Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice. , 1998, The Journal of parasitology.

[67]  M. Bajaj‐Elliott,et al.  Differential Regulation of β-Defensin Gene Expression during Cryptosporidium parvum Infection , 2004, Infection and Immunity.

[68]  D. Philpott,et al.  Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.

[69]  Kehe Huang,et al.  Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo , 2007, Biological Trace Element Research.

[70]  Qing He,et al.  Reactive Nitrogen and Oxygen Species Ameliorate Experimental Cryptosporidiosis in the Neonatal BALB/c Mouse Model , 1999, Infection and Immunity.

[71]  R. Kastelein,et al.  Novel IL-12 family members shed light on the orchestration of Th1 responses , 2003, Trends in Immunology.

[72]  M. Jones,et al.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. , 1999, Vaccine.

[73]  J. Gobert,et al.  Kinetics of mucosal ileal gamma-interferon response during cryptosporidiosis in immunocompetent neonatal mice , 1996, Parasitology Research.

[74]  G. Bancroft,et al.  Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice , 1992, Infection and immunity.

[75]  R. Fayer,et al.  Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. , 1999, Vaccine.

[76]  J. Crabb.  Antibody-based immunotherapy of cryptosporidiosis. , 1998, Advances in parasitology.

[77]  Y. Na,et al.  Role of anti-oxidant preparation (oxi-guard) on Cryptosporidium parvum infection in albino mice. , 2001 .

[78]  J. Mead,et al.  Susceptibility to Cryptosporidium parvum Infections in Cytokine- and Chemokine-Receptor Knockout Mice , 2002, The Journal of parasitology.

[79]  D. Havlir,et al.  Cryptosporidium infection and CD4 counts. , 1992, Annals of internal medicine.

[80]  J. Volanakis.  The human complement system in health and disease , 1998 .

[81]  G. Bancroft,et al.  Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice , 1994, Parasite immunology.

[82]  W. Davis,et al.  IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. , 1998, Journal of immunology.

[83]  R. Pollok,et al.  Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. , 2001, Gastroenterology.

[84]  R. Sidwell,et al.  Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. , 1991, The Journal of protozoology.

[85]  G. Leitch,et al.  Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum , 1994, Infection and immunity.

[86]  S. McDonald,et al.  Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. , 2004, The Journal of infectious diseases.

[87]  N. Lynch,et al.  Differential Expression of the Murine Mannose-Binding Lectins A and C in Lymphoid and Nonlymphoid Organs and Tissues 1 , 2003, The Journal of Immunology.

[88]  R. Fayer,et al.  Recombinant bovine interleukin-12 stimulates a gut immune response but does not provide resistance to Cryptosporidium parvum infection in neonatal calves. , 2006, Veterinary parasitology.